Compazine and Cinvanti drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Compazine (prochlorperazine maleate) and Cinvanti (aprepitant). Common drug interactions include respiratory failure among females and syncope among males.

The phase IV clinical study analyzes what interactions people have when they take Compazine and Cinvanti. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Compazine?

Compazine has active ingredients of prochlorperazine maleate. It is often used in indigestion. eHealthMe is studying from 13,646 Compazine users. Check the latest studies of Compazine.

What is Cinvanti?

Cinvanti has active ingredients of aprepitant. eHealthMe is studying from 150 Cinvanti users. Check the latest studies of Cinvanti.

On Jul, 17, 2026

15 people who take Compazine and Cinvanti together, and have interactions are studied.

Compazine and Cinvanti drug interactions.

What are the common drug interactions of Compazine and Cinvanti, by gender? *:

female:

Respiratory failure (inadequate gas exchange by the respiratory system)
Neutropenic colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition)
Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
Blood glucose increased
Dizziness

male:

Syncope (loss of consciousness with an inability to maintain postural tone)
Acute respiratory failure
Anaemia (lack of blood)
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Neutropenia (an abnormally low number of neutrophils)
Pneumonia

What are the common drug interactions of Compazine and Cinvanti, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Blood glucose increased

30-39:

n/a

40-49:

n/a

50-59:

Acute respiratory failure
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Pneumonia

60+:

Neutropenic colitis (inflammation of the cecum, often with involvement of the ascending colon and ileum, a life threatening condition)
Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
Syncope (loss of consciousness with an inability to maintain postural tone)
Anaemia (lack of blood)
Neutropenia (an abnormally low number of neutrophils)
Respiratory failure (inadequate gas exchange by the respiratory system)

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 7 people, 46.67%
Burkitt Lymphoma (cancer of the lymphatic system): 4 people, 26.67%
Diarrhea: 4 people, 26.67%
Non-Small Cell Lung Cancer Stage Iv: 3 people, 20.00%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 20.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 13.33%
Rashes (redness): 2 people, 13.33%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 13.33%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 13.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Compazine and Cinvanti?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously